Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients
Clinical trial NCT00499889 · TERMINATED
Trial details
- NCT number
- NCT00499889
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2009-11-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.